Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus
Abstract
Troglitazone is a new insulin-sensitizing agent used to treat type 2 diabetes mellitus. The mechanism by which troglitazone exerts its effect on systemic glucose metabolism is unknown.To determine the effects of 6 months of troglitazone monotherapy on glucose metabolism in patients with type 2 diabetes mellitus.Randomized, double-blind, placebo-controlled trial.Six general clinical research centers at university hospitals.93 patients (mean age,...
Paper Details
Title
Metabolic Effects of Troglitazone Monotherapy in Type 2 Diabetes Mellitus
Published Date
Feb 1, 1998
Journal
Volume
128
Issue
3
Pages
176 - 176
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History